Correlation Between Maravai Lifesciences and Eterna Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Maravai Lifesciences and Eterna Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Maravai Lifesciences and Eterna Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Maravai Lifesciences Holdings and Eterna Therapeutics, you can compare the effects of market volatilities on Maravai Lifesciences and Eterna Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Maravai Lifesciences with a short position of Eterna Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Maravai Lifesciences and Eterna Therapeutics.

Diversification Opportunities for Maravai Lifesciences and Eterna Therapeutics

0.78
  Correlation Coefficient

Poor diversification

The 3 months correlation between Maravai and Eterna is 0.78. Overlapping area represents the amount of risk that can be diversified away by holding Maravai Lifesciences Holdings and Eterna Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Eterna Therapeutics and Maravai Lifesciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Maravai Lifesciences Holdings are associated (or correlated) with Eterna Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Eterna Therapeutics has no effect on the direction of Maravai Lifesciences i.e., Maravai Lifesciences and Eterna Therapeutics go up and down completely randomly.

Pair Corralation between Maravai Lifesciences and Eterna Therapeutics

Given the investment horizon of 90 days Maravai Lifesciences Holdings is expected to generate 1.08 times more return on investment than Eterna Therapeutics. However, Maravai Lifesciences is 1.08 times more volatile than Eterna Therapeutics. It trades about 0.02 of its potential returns per unit of risk. Eterna Therapeutics is currently generating about -0.12 per unit of risk. If you would invest  664.00  in Maravai Lifesciences Holdings on September 19, 2024 and sell it today you would lose (83.00) from holding Maravai Lifesciences Holdings or give up 12.5% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Maravai Lifesciences Holdings  vs.  Eterna Therapeutics

 Performance 
       Timeline  
Maravai Lifesciences 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Maravai Lifesciences Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unfluctuating performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in January 2025. The recent confusion may also be a sign of long-lasting up-swing for the firm traders.
Eterna Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Eterna Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Maravai Lifesciences and Eterna Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Maravai Lifesciences and Eterna Therapeutics

The main advantage of trading using opposite Maravai Lifesciences and Eterna Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Maravai Lifesciences position performs unexpectedly, Eterna Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Eterna Therapeutics will offset losses from the drop in Eterna Therapeutics' long position.
The idea behind Maravai Lifesciences Holdings and Eterna Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.

Other Complementary Tools

Stocks Directory
Find actively traded stocks across global markets
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world